$117 Million is the total value of EMORY UNIVERSITY's 44 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 53.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WVE | Sell | WAVE LIFE SCIENCES LTD | $2,212,000 | +5.7% | 63,013 | -34.5% | 1.90% | +14.5% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $2,146,000 | -10.1% | 21,956 | -4.8% | 1.84% | -2.5% |
| TRN | Sell | TRINITY INDS INC | $2,057,000 | +12.3% | 54,906 | -4.3% | 1.76% | +21.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $2,036,000 | -6.2% | 50,813 | -15.1% | 1.75% | +1.7% |
| STX | Sell | SEAGATE TECHNOLOGY PLC | $1,973,000 | +17.7% | 47,154 | -6.7% | 1.69% | +27.6% |
| ZGNX | Sell | ZOGENIX INC | $1,956,000 | -61.8% | 48,843 | -66.6% | 1.68% | -58.6% |
| MSFT | Sell | MICROSOFT CORP | $1,938,000 | +14.2% | 22,655 | -0.5% | 1.66% | +23.8% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $1,935,000 | +3.6% | 24,945 | -18.2% | 1.66% | +12.3% |
| CBRE | Sell | CBRE GROUP INCcl a | $1,831,000 | +5.9% | 42,266 | -7.4% | 1.57% | +14.8% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $1,822,000 | -24.9% | 14,344 | -30.6% | 1.56% | -18.6% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $1,788,000 | +2.5% | 45,441 | -19.1% | 1.53% | +11.2% |
| SGEN | Sell | SEATTLE GENETICS INC | $1,695,000 | -13.4% | 31,683 | -11.9% | 1.45% | -6.2% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $1,685,000 | -31.5% | 17,044 | -17.1% | 1.45% | -25.8% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $1,662,000 | -9.4% | 51,632 | -2.1% | 1.43% | -1.8% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $1,660,000 | -31.8% | 131,363 | -16.5% | 1.42% | -26.1% |
| VSAR | Exit | VERSARTIS INC | $0 | – | -96,222 | -100.0% | -0.19% | – |
| LVNTA | Exit | LIBERTY INTERACTIVE CORP | $0 | – | -26,547 | -100.0% | -1.21% | – |
| LSXMK | Exit | LIBERTY MEDIA CORP DELAWARE | $0 | – | -37,930 | -100.0% | -1.26% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -100,821 | -100.0% | -1.27% | – |
| BIVV | Exit | BIOVERATIV INC | $0 | – | -28,418 | -100.0% | -1.28% | – |
| LEXEA | Exit | LIBERTY EXPEDIA HOLDINGS | $0 | – | -30,640 | -100.0% | -1.29% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -112,084 | -100.0% | -1.30% | – |
| KMI | Exit | KINDER MORGAN INC DEL | $0 | – | -86,463 | -100.0% | -1.31% | – |
| COMM | Exit | COMMSCOPE HLDG CO INC | $0 | – | -50,472 | -100.0% | -1.33% | – |
| ACGL | Exit | ARCH CAP GROUP LTDord | $0 | – | -17,022 | -100.0% | -1.33% | – |
| WLTW | Exit | WILLIS TOWERS WATSON PUB LTD | $0 | – | -10,874 | -100.0% | -1.33% | – |
| VSAT | Exit | VIASAT INC | $0 | – | -26,368 | -100.0% | -1.34% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -26,837 | -100.0% | -1.34% | – |
| QRTEA | Exit | LIBERTY INTERACTIVE CORP | $0 | – | -72,071 | -100.0% | -1.34% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -33,975 | -100.0% | -1.35% | – |
| WBC | Exit | WABCO HLDGS INC | $0 | – | -11,781 | -100.0% | -1.38% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -170,507 | -100.0% | -1.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.